The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

PHASE2CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Immune Thrombocytopenia
Interventions
DRUG

Dexamethasone

Dexamethasone, iv, 40 mg/d, for 4 days (The 4-day course of dexamethasone was repeated in the case of lack of response by day 10)

DRUG

ATRA

ATRA, po,10mg bid, for 12 weeks

Trial Locations (1)

100044

Peking University Insititute of Hematology, Peking University People's Hospital, Beijing

All Listed Sponsors
collaborator

Beijing Hospital

OTHER_GOV

collaborator

Navy General Hospital, Beijing

OTHER

collaborator

Beijing Aerospace General Hospital

OTHER

collaborator

Qilu Hospital of Shandong University

OTHER

collaborator

Beijing Tongren Hospital

OTHER

lead

Peking University People's Hospital

OTHER

NCT04217148 - The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia | Biotech Hunter | Biotech Hunter